ChromaDex (CDXC)
(Delayed Data from NSDQ)
$3.42 USD
-0.10 (-2.84%)
Updated May 10, 2024 04:00 PM ET
After-Market: $3.40 -0.02 (-0.58%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth F Momentum B VGM
Brokerage Reports
0 items in cart
ChromaDex Corporation [CDXC]
Reports for Purchase
Showing records 61 - 80 ( 111 total )
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Asian Market Turmoil Impeding Growth; Long-Term Attractiveness; Reiterate Buy; Modulating Target to $6
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
1Q19 Financial Results Reported; Cash Replenished; E-Commerce Sales Accelerating; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
TRU NIAGEN Canada Distribution Expansion; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Revising Revenue and Spending Projections; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
2018 Financial Results Reported; Revenue and Earnings Largely In-Line; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Fresh From Patent Validation Victory, ChromaDex Goes on the Attack; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Partnership Inked With Nestlé Health Sciences; Raising Target to $7
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Top-Line and Bottom-Line Miss for 3Q18; Reducing Price Target to $6
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
TRU NIAGEN PRO Launched in Partnership With Natural Partners Fullscript; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Chinese Province Strategic Partnership; Patent Infringement Complaint Filed; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Stock Decline Appears Unwarranted; Attractive Entry Point; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
2Q18 Financial Results Reported; Looking Ahead to Profitability; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
TRU NIAGEN New Zealand Launch Through Partnership; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Watsons Retail Partnership on TRU NIAGEN Extended and Expanded; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
New Human Data May Indicate Role for NIAGEN in Enhancing Liver Health; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Chief Marketing Officer Appointed; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
1Q 2018 Results Reported; Top-Line In-Line; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Inter Partes Review Trial; Management Changes Effected; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: ChromaDex Corporation
Industry: Medical - Biomedical and Genetics
Clinical Trial Data Underscore NIAGEN Health Benefits; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R